Radiopharmaceuticals Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 101

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report contains market size and forecasts of Radiopharmaceuticals in US, including the following market information:

US Radiopharmaceuticals Market Revenue, 2015-2020, 2021-2026, ($ millions)

US Radiopharmaceuticals Market Consumption, 2015-2020, 2021-2026, (K Dose)

US Radiopharmaceuticals Production Capacity, 2015-2020, 2021-2026, (K Dose)

Top Five Competitors in US Radiopharmaceuticals Market 2019 (%)

The global Radiopharmaceuticals market was valued at 5929.1 million in 2019 and is projected to reach US$ 7964.2 million by 2026, at a CAGR of 7.7% during the forecast period. While the Radiopharmaceuticals market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Radiopharmaceuticals production and consumption in US

Total Market by Segment:

US Radiopharmaceuticals Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Dose)

US Radiopharmaceuticals Market Segment Percentages, By Type, 2019 (%)

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

US Radiopharmaceuticals Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Dose)

US Radiopharmaceuticals Market Segment Percentages, By Application, 2019 (%)

- Oncology

- Cardiology

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Radiopharmaceuticals Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Radiopharmaceuticals Market Competitors Revenues Share in US, by Players 2019 (%)

Total US Radiopharmaceuticals Market Competitors Sales, by Players 2015-2020 (Estimated), (K Dose)

Total US Radiopharmaceuticals Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

Radiopharmaceuticals Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: US Radiopharmaceuticals Overall Market Size
2.1 US Radiopharmaceuticals Market Size: 2020 VS 2026
2.2 US Radiopharmaceuticals Revenue, Prospects & Forecasts: 2015-2026
2.3 US Radiopharmaceuticals Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Radiopharmaceuticals Players in US (including Foreign and Local Companies)
3.2 Top US Radiopharmaceuticals Companies Ranked by Revenue
3.3 US Radiopharmaceuticals Revenue by Companies (including Foreign and Local Companies)
3.4 US Radiopharmaceuticals Sales by Companies (including Foreign and Local Companies)
3.5 US Radiopharmaceuticals Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Radiopharmaceuticals Companies in US, by Revenue in 2019
3.7 US Manufacturers Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals Players in US
3.8.1 List of US Tier 1 Radiopharmaceuticals Companies
3.8.2 List of US Tier 2 and Tier 3 Radiopharmaceuticals Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Radiopharmaceuticals Market Size Markets, 2020 & 2026
4.1.2 Diagnostic Radioisotopes
4.1.3 Therapeutic Radioisotopes
4.2 By Type - US Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - US Radiopharmaceuticals Revenue, 2015-2020
4.2.2 By Type - US Radiopharmaceuticals Revenue, 2021-2026
4.2.3 By Type - US Radiopharmaceuticals Revenue Market Share, 2015-2026
4.3 By Type - US Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - US Radiopharmaceuticals Sales, 2015-2020
4.3.2 By Type - US Radiopharmaceuticals Sales, 2021-2026
4.3.3 By Type - US Radiopharmaceuticals Sales Market Share, 2015-2026
4.4 By Type - US Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Radiopharmaceuticals Market Size, 2020 & 2026
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - US Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - US Radiopharmaceuticals Revenue, 2015-2020
5.2.2 By Application - US Radiopharmaceuticals Revenue, 2021-2026
5.2.3 By Application - US Radiopharmaceuticals Revenue Market Share, 2015-2026
5.3 By Application - US Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - US Radiopharmaceuticals Sales, 2015-2020
5.3.2 By Application - US Radiopharmaceuticals Sales, 2021-2026
5.3.3 By Application - US Radiopharmaceuticals Sales Market Share, 2015-2026
5.4 By Application - US Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporate Summary
6.1.2 Bracco Imaging Business Overview
6.1.3 Bracco Imaging Radiopharmaceuticals Major Product Offerings
6.1.4 Bracco Imaging Sales and Revenue in US (2015-2020)
6.1.5 Bracco Imaging Key News
6.2 Bayer
6.2.1 Bayer Corporate Summary
6.2.2 Bayer Business Overview
6.2.3 Bayer Radiopharmaceuticals Major Product Offerings
6.2.4 Bayer Sales and Revenue in US (2015-2020)
6.2.5 Bayer Key News
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporate Summary
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Radiopharmaceuticals Major Product Offerings
6.3.4 Mallinckrodt Sales and Revenue in US (2015-2020)
6.3.5 Mallinckrodt Key News
6.4 Nordion
6.4.1 Nordion Corporate Summary
6.4.2 Nordion Business Overview
6.4.3 Nordion Radiopharmaceuticals Major Product Offerings
6.4.4 Nordion Sales and Revenue in US (2015-2020)
6.4.5 Nordion Key News
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporate Summary
6.5.2 Triad Isotopes Business Overview
6.5.3 Triad Isotopes Radiopharmaceuticals Major Product Offerings
6.5.4 Triad Isotopes Sales and Revenue in US (2015-2020)
6.5.5 Triad Isotopes Key News
6.6 Lantheus
6.6.1 Lantheus Corporate Summary
6.6.2 Lantheus Business Overview
6.6.3 Lantheus Radiopharmaceuticals Major Product Offerings
6.6.4 Lantheus Sales and Revenue in US (2015-2020)
6.6.5 Lantheus Key News
6.7 IBA Group
6.6.1 IBA Group Corporate Summary
6.6.2 IBA Group Business Overview
6.6.3 IBA Group Radiopharmaceuticals Major Product Offerings
6.4.4 IBA Group Sales and Revenue in US (2015-2020)
6.7.5 IBA Group Key News
6.8 GE Healthcare
6.8.1 GE Healthcare Corporate Summary
6.8.2 GE Healthcare Business Overview
6.8.3 GE Healthcare Radiopharmaceuticals Major Product Offerings
6.8.4 GE Healthcare Sales and Revenue in US (2015-2020)
6.8.5 GE Healthcare Key News
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporate Summary
6.9.2 China Isotope & Radiation Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceuticals Major Product Offerings
6.9.4 China Isotope & Radiation Sales and Revenue in US (2015-2020)
6.9.5 China Isotope & Radiation Key News
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporate Summary
6.10.2 Jubilant Pharma Business Overview
6.10.3 Jubilant Pharma Radiopharmaceuticals Major Product Offerings
6.10.4 Jubilant Pharma Sales and Revenue in US (2015-2020)
6.10.5 Jubilant Pharma Key News
6.11 Eli Lilly
6.11.1 Eli Lilly Corporate Summary
6.11.2 Eli Lilly Radiopharmaceuticals Business Overview
6.11.3 Eli Lilly Radiopharmaceuticals Major Product Offerings
6.11.4 Eli Lilly Sales and Revenue in US (2015-2020)
6.11.5 Eli Lilly Key News
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporate Summary
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Major Product Offerings
6.12.4 Advanced Accelerator Applications Sales and Revenue in US (2015-2020)
6.12.5 Advanced Accelerator Applications Key News
6.13 SIEMENS
6.13.1 SIEMENS Corporate Summary
6.13.2 SIEMENS Radiopharmaceuticals Business Overview
6.13.3 SIEMENS Radiopharmaceuticals Major Product Offerings
6.13.4 SIEMENS Sales and Revenue in US (2015-2020)
6.13.5 SIEMENS Key News
6.14 Dongcheng
6.14.1 Dongcheng Corporate Summary
6.14.2 Dongcheng Radiopharmaceuticals Business Overview
6.14.3 Dongcheng Radiopharmaceuticals Major Product Offerings
6.14.4 Dongcheng Sales and Revenue in US (2015-2020)
6.14.5 Dongcheng Key News
6.15 Navidea
6.15.1 Navidea Corporate Summary
6.15.2 Navidea Radiopharmaceuticals Business Overview
6.15.3 Navidea Radiopharmaceuticals Major Product Offerings
6.15.4 Navidea Sales and Revenue in US (2015-2020)
6.15.5 Navidea Key News

7 Radiopharmaceuticals Production Capacity, Export and Import Analysis
7.1 Radiopharmaceuticals Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Radiopharmaceuticals Production Capacity, 2015-2026
7.1.2 US Radiopharmaceuticals Production 2015-2026
7.1.3 US Radiopharmaceuticals Production Value 2015-2026
7.2 Key Local Radiopharmaceuticals Manufacturers in US
7.2.1 US Key Local Radiopharmaceuticals Manufacturers Production Capacity
7.2.2 US Key Local Radiopharmaceuticals Manufacturers Production
7.2.3 US Key Local Radiopharmaceuticals Manufacturers Production Value
7.2.4 The Proportion of Radiopharmaceuticals Production Sold in US and Sold Other Than US by Manufacturers
7.3 Radiopharmaceuticals Export and Import in US
7.3.1 US Radiopharmaceuticals Export Market
7.3.2 US Radiopharmaceuticals Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Radiopharmaceuticals Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Radiopharmaceuticals Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Radiopharmaceuticals Distributors and Sales Agents in US

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables
Table 1. Key Players of Radiopharmaceuticals in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Radiopharmaceuticals Revenue Share by Companies, 2015-2020
Table 5. US Radiopharmaceuticals Sales by Companies, (K Dose), 2015-2020
Table 6. US Radiopharmaceuticals Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Radiopharmaceuticals Price (2015-2020) (USD/Dose)
Table 8. US Manufacturers Radiopharmaceuticals Product Type
Table 9. List of US Tier 1 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Radiopharmaceuticals Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Radiopharmaceuticals Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Radiopharmaceuticals Sales in US (K Dose), 2015-2020
Table 14. By Type - Radiopharmaceuticals Sales in US (K Dose), 2021-2026
Table 15. By Application - Radiopharmaceuticals Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Radiopharmaceuticals Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Radiopharmaceuticals Sales in US, (K Dose), 2015-2020
Table 18. By Application - Radiopharmaceuticals Sales in US, (K Dose), 2021-2026
Table 19. Bracco Imaging Corporate Summary
Table 20. Bracco Imaging Radiopharmaceuticals Product Offerings
Table 21. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Bayer Corporate Summary
Table 23. Bayer Radiopharmaceuticals Product Offerings
Table 24. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Mallinckrodt Corporate Summary
Table 26. Mallinckrodt Radiopharmaceuticals Product Offerings
Table 27. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Nordion Corporate Summary
Table 29. Nordion Radiopharmaceuticals Product Offerings
Table 30. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 31. Triad Isotopes Corporate Summary
Table 32. Triad Isotopes Radiopharmaceuticals Product Offerings
Table 33. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 34. Lantheus Corporate Summary
Table 35. Lantheus Radiopharmaceuticals Product Offerings
Table 36. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 37. IBA Group Corporate Summary
Table 38. IBA Group Radiopharmaceuticals Product Offerings
Table 39. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 40. GE Healthcare Corporate Summary
Table 41. GE Healthcare Radiopharmaceuticals Product Offerings
Table 42. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 43. China Isotope & Radiation Corporate Summary
Table 44. China Isotope & Radiation Radiopharmaceuticals Product Offerings
Table 45. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 46. Jubilant Pharma Corporate Summary
Table 47. Jubilant Pharma Radiopharmaceuticals Product Offerings
Table 48. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Radiopharmaceuticals Product Offerings
Table 51. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 52. Advanced Accelerator Applications Corporate Summary
Table 53. Advanced Accelerator Applications Radiopharmaceuticals Product Offerings
Table 54. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 55. SIEMENS Corporate Summary
Table 56. SIEMENS Radiopharmaceuticals Product Offerings
Table 57. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 58. Dongcheng Corporate Summary
Table 59. Dongcheng Radiopharmaceuticals Product Offerings
Table 60. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 61. Navidea Corporate Summary
Table 62. Navidea Radiopharmaceuticals Product Offerings
Table 63. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 64. Radiopharmaceuticals Production Capacity (K Dose) of Local Manufacturers in US, 2015-2020
Table 65. Radiopharmaceuticals Production (K Dose) of Local Manufacturers in US, 2015-2020
Table 66. US Radiopharmaceuticals Production Market Share of Local Manufacturers, 2015-2020
Table 67. Radiopharmaceuticals Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 68. US Radiopharmaceuticals Production Value Market Share of Local Manufacturers, 2015-2020
Table 69. The Percentage of Radiopharmaceuticals Production Sold in US and Sold Other Than US by Manufacturers
Table 70. The Percentage of Radiopharmaceuticals Production Sold in US and Sold Other Than US by Manufacturers
Table 71. Dangeguojia Radiopharmaceuticals Sales (Consumption), Production, Export and Import, 2015-2020
Table 72. Raw Materials and Suppliers
Table 73. Radiopharmaceuticals Downstream Clients in US
Table 74. Radiopharmaceuticals Distributors and Sales Agents in US
List of Figures
Figure 1. Radiopharmaceuticals Segment by Type
Figure 2. Radiopharmaceuticals Segment by Application
Figure 3. Dangeguojia Radiopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Radiopharmaceuticals Market Size in US, (US$, Mn) & (K Dose): 2020 VS 2026
Figure 6. US Radiopharmaceuticals Revenue, 2015-2026 (US$, Mn)
Figure 7. Radiopharmaceuticals Sales in US: 2015-2026 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceuticals Revenue in 2019
Figure 9. By Type - US Radiopharmaceuticals Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Radiopharmaceuticals Market Share, 2015-2020
Figure 11. By Type - US Radiopharmaceuticals Market Share, 2020-2026
Figure 12. By Type - US Radiopharmaceuticals Price (USD/Dose), 2015-2026
Figure 13. By Application - Radiopharmaceuticals Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Radiopharmaceuticals Market Share, 2015-2020
Figure 15. By Application - US Radiopharmaceuticals Market Share, 2020-2026
Figure 16. By Application -US Radiopharmaceuticals Price (USD/Dose), 2015-2026
Figure 17. US Radiopharmaceuticals Production Capacity (K Dose), 2015-2026
Figure 18. US Radiopharmaceuticals Actual Output (K Dose), 2015-2026
Figure 19. US Radiopharmaceuticals Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Radiopharmaceuticals Export Destination, 2019
Figure 21. The Source of Imports of US Radiopharmaceuticals, 2019
Figure 22. PEST Analysis for US Radiopharmaceuticals Market in 2020
Figure 23. Radiopharmaceuticals Market Opportunities & Trends in US
Figure 24. Radiopharmaceuticals Market Drivers in US
Figure 25. Radiopharmaceuticals Market Restraints in US
Figure 26. Radiopharmaceuticals Industry Value Chain
  • Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) - Global Forecast to 2025
    Published: 03-Aug-2020        Price: US 4950 Onwards        Pages: 226
    “Radiation dose management marketis projected to grow at CAGR of 13.9% from 2020 to 2025” The global radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9% from 2020 to 2025. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiolog......
  • Global Radiopharmaceutical Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 17-Jul-2020        Price: US 5900 Onwards        Pages: 132
    Radiopharmaceutical market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Radiopharmaceutical m......
  • Global Radiation Dose Management Market Size, Status and Forecast 2020-2026
    Published: 17-Jul-2020        Price: US 3900 Onwards        Pages: 98
    Radiation Dose Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiation Dose Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Landauer - Sectra AB - Afga-Geva......
  • 2020-2029 Report on Global Radiopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 14-Jul-2020        Price: US 2500 Onwards        Pages: 122
    The global Radiopharmaceuticals market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this ind......
  • Global Radiopharmaceutical Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 14-Jul-2020        Price: US 3200 Onwards        Pages: 163
    According to HJ Research's study, the global Radiopharmaceutical market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Radiopharmaceutical market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 202......
  • COVID-19 Outbreak-Global Radiation Dose Management Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 119
    The radiation dose management channel includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interative reconstruction software. The Radiation Dose Management market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply ch......
  • COVID-19 Outbreak-Global Radiopharmaceutical Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 30-Jun-2020        Price: US 3660 Onwards        Pages: 109
    The Radiopharmaceutical market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products,......
  • COVID-19 Outbreak-Global Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 23-Jun-2020        Price: US 3660 Onwards        Pages: 121
    The Radiopharmaceuticals market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, indust......
  • Radiopharmaceutical Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 08-Jun-2020        Price: US 2280 Onwards        Pages: 41
    Summary According to 99Strategy, the Global Radiopharmaceutical Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Radiopharmaceutical market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs